Head to head for first-timers
CoreAge Rx vs NuuVim
CoreAge Rx and NuuVim both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #32 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxNuuVim
Rank #170 for first-timers · Grade C
Mama-Match
Best for: Moms looking for the lowest entry price to try a GLP-1, who don't mind not yet knowing the price after the first period.
Visit NuuVimThe verdict for a first step
CoreAge Rx edges out NuuVim on the Mama-Match Score, 73 to 55 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
NuuVim is still a genuine option — the lowest new-patient price on this roster — $79/mo semaglutide, $133/mo tirzepatide — with the genuine rarity of charging the same for an oral tablet as for the injection, though it doesn't publish the refill rate or a verifiable state list. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | NuuVim |
|---|---|---|
| Mama-Match Score | 73/100 · C | 55/100 · C |
| Overall rank | #32 | #170 |
| Semaglutide | $99/mo | $79/mo |
| Tirzepatide | $149/mo | $133/mo |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not confirmed (see note) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #32 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
NuuVim
Rank #170 · Grade C
What we like
- The lowest new-patient price on this roster: $79/mo semaglutide, $133/mo tirzepatide
- Same price for the oral tablet as for the injection — a genuine rarity in this category
- LegitScript certification and HIPAA compliance
The caveats
- Doesn't publish the refill rate — the low price is specifically for new patients
- A list of states served couldn't be verified live
- Its brand-name options (Ozempic, Zepbound) cost far more than the manufacturer's direct self-pay channels
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuuVim with the other providers we review for women.
Or browse the full comparison hub.